Skip to main content
English

Suche

  1. Home
  2. Suche

Webseiten-Inhalte

Detailsite | MedUni Vienna ... Forschungsinitiative von ALK-abhängigen Krebserkrankungen ERIA bildet das Herzstück eines erfolgreichen Antrags (ALKATRAS) für ein europäisches Trainingsnetzwerk (ETN). Suzanne Turner von der Universität von Cambridge, Lukas Kenner (Ludwig Boltzmann Institut für Krebsforschung (LBI-CR) sowie MedUni Wien) sowie Olaf... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?tx_news_pi1%5Bnews%5D=2869&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=e5fc2c48e5b9272bc434a4f31c2e5220
Detailsite | MedUni Vienna ... Forschungsinitiative von ALK-abhängigen Krebserkrankungen ERIA bildet das Herzstück eines erfolgreichen Antrags (ALKATRAS) für ein europäisches Trainingsnetzwerk (ETN). Suzanne Turner von der Universität von Cambridge, Lukas Kenner (Ludwig Boltzmann Institut für Krebsforschung (LBI-CR) sowie MedUni Wien) sowie Olaf... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?cHash=e5fc2c48e5b9272bc434a4f31c2e5220&tx_news_pi1%5Baction%5D=detail&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Bnews%5D=2869
News ...-abhängigen Krebserkrankungen ERIA bildet das Herzstück eines erfolgreichen Antrags (ALKATRAS) für ein europäisches Trainingsnetzwerk (ETN). Suzanne Turner von der Universität von Cambridge, Lukas Kenner (Ludwig Boltzmann Institut für Krebsforschung (LBI-CR) sowie MedUni Wien) sowie Olaf Merkel und Gerda... https://www.meduniwien.ac.at/web/index.php?id=131&L=3&tx_news_pi1%5Bnews%5D=2869&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=e5fc2c48e5b9272bc434a4f31c2e5220
Detailsite | MedUni Vienna ... Forschungsinitiative von ALK-abhängigen Krebserkrankungen ERIA bildet das Herzstück eines erfolgreichen Antrags (ALKATRAS) für ein europäisches Trainingsnetzwerk (ETN). Suzanne Turner von der Universität von Cambridge, Lukas Kenner (Ludwig Boltzmann Institut für Krebsforschung (LBI-CR) sowie MedUni Wien) sowie Olaf... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/in-german-eu-grant-fuer-krebsforschungs-trainingsnetzwerk-unter-mitwirkung-der-meduni-wien/?L=3
Detailsite | MedUni Vienna ... led by Lukas Kenner of MedUni Vienna has now identified a gene, AF1q, as being substantially responsible for this and recognized it as a possible starting point for more accurate diagnosis and potential targeted therapeutic approaches. (Vienna, 15-06-2015) A particular human gene variant makes breast cancer cells more aggressive. Not only are these more resistant to chemotherapy but also leave the primary tumour and establish themselves in other parts of the body in the form of metastases. An international group of researchers led by Lukas Kenner of MedUni Vienna and William Tse at James Graham Brown... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/breast-cancer-cells-form-metastases-the-responsible-gene-is-identified/?L=3
Detailsite | MedUni Vienna ... led by Lukas Kenner of MedUni Vienna has now identified a gene, AF1q, as being substantially responsible for this and recognized it as a possible starting point for more accurate diagnosis and potential targeted therapeutic approaches. (Vienna, 15-06-2015) A particular human gene variant makes breast cancer cells more aggressive. Not only are these more resistant to chemotherapy but also leave the primary tumour and establish themselves in other parts of the body in the form of metastases. An international group of researchers led by Lukas Kenner of MedUni Vienna and William Tse at James Graham Brown... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?tx_news_pi1%5Bnews%5D=2915&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=14478592298920cd61047a6b8595a883
Detailsite | MedUni Vienna ... led by Lukas Kenner of MedUni Vienna has now identified a gene, AF1q, as being substantially responsible for this and recognized it as a possible starting point for more accurate diagnosis and potential targeted therapeutic approaches. (Vienna, 15-06-2015) A particular human gene variant makes breast cancer cells more aggressive. Not only are these more resistant to chemotherapy but also leave the primary tumour and establish themselves in other parts of the body in the form of metastases. An international group of researchers led by Lukas Kenner of MedUni Vienna and William Tse at James Graham Brown... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?cHash=14478592298920cd61047a6b8595a883&tx_news_pi1%5Baction%5D=detail&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Bnews%5D=2915
Detailsite | MedUni Vienna ... Lukas Kenner for the Clinical Institute of Pathology at MedUni Vienna. Scientists believe that in conventional chemotherapy, cancer cells which spread through the body are destroyed, but not the original “cancer stem cells” by which the tumour is produced. As Lukas Kenner, Director of the Institute of... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?tx_news_pi1%5Bnews%5D=3219&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=3b4d0528c57007cdb6cdc9967ba6eea2
Detailsite | MedUni Vienna ..., infertility and secondary cancers. Up to 40 percent of children diagnosed with ALCL also suffer a relapse, which requires additional chemotherapy.“The origins of ALCL could be traced to a gene disorder in the development of blood-producing stem cells, which are located in the thymus,” explains Lukas Kenner for the Clinical Institute of Pathology at MedUni Vienna. Scientists believe that in conventional chemotherapy, cancer cells which spread through the body are destroyed, but not the original “cancer stem cells” by which the tumour is produced. As Lukas Kenner, Director of the Institute of Laboratory... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/cause-of-an-aggressive-form-of-childhood-cancer-identified/?L=3
Jan Pencik erhält Max-Kade-Stipendium der Österreichischen Akademie der Wissenschaften ... 2010 am LBI-CR (Ludwig Boltzmann Institute for Cancer Research) in Wien bei Lukas Kenner seine Doktorarbeit begann. Nach dem Abschluss seines PhD-Studiums arbeitete er als PostDoc in der Arbeitsgruppe von Lukas Kenner am Klinischen Institut für Pathologie der MedUni Wien und am Center for Biomarker... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2019/news-im-jaenner-2019/jan-pencik-erhaelt-max-kade-stipendium-der-oesterreichischen-akademie-der-wissenschaften/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=13&cHash=b6880a0106e790a7bc7e97aaa8e340b4